Orchestra BioMed Holdings, Inc. Variable Lease, Cost
Orchestra BioMed Holdings, Inc. (OBIO) reported Variable Lease, Cost of $38.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. variable lease, cost for the quarter ending 2026-06-30 was $38.00K, a 100.00% increase year-over-year.
- Orchestra BioMed Holdings, Inc. variable lease, cost for the quarter ending 2026-03-31 was $21.00K, a 32.26% decline year-over-year.
- Orchestra BioMed Holdings, Inc. variable lease, cost for the quarter ending 2025-12-31 was $19.00K, a 58.70% decline year-over-year.
- Orchestra BioMed Holdings, Inc. variable lease, cost for the quarter ending 2025-09-30 was $35.00K, a 105.88% increase year-over-year.
- Orchestra BioMed Holdings, Inc. variable lease, cost for fiscal 2025 was $104.00K, a 36.20% decline from fiscal 2024.
- Orchestra BioMed Holdings, Inc. variable lease, cost for fiscal 2024 was $163.00K, a 1258.33% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. variable lease, cost for fiscal 2023 was $12.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $38.00K 10-Q · filed 2026-08-10 | $59.00K 10-Q · filed 2026-08-10 | $78.00K derived: sum of 3 quarters · filed 2026-08-10 | $113.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $21.00K 10-Q · filed 2026-05-12 | $40.00K derived: sum of 2 quarters · filed 2026-05-12 | $75.00K derived: sum of 3 quarters · filed 2026-05-12 | $94.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $54.00K derived: sum of 2 quarters · filed 2026-03-12 | $73.00K derived: sum of 3 quarters · filed 2026-08-10 | $104.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $35.00K 10-Q · filed 2025-11-10 | $54.00K derived: sum of 2 quarters · filed 2026-08-10 | $85.00K 10-Q · filed 2025-11-10 | $131.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $19.00K 10-Q · filed 2026-08-10 | $50.00K 10-Q · filed 2026-08-10 | $96.00K derived: sum of 3 quarters · filed 2026-08-10 | $113.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $31.00K 10-Q · filed 2026-05-12 | $77.00K derived: sum of 2 quarters · filed 2026-05-12 | $94.00K derived: sum of 3 quarters · filed 2026-05-12 | $132.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $63.00K derived: sum of 2 quarters · filed 2026-03-12 | $101.00K derived: sum of 3 quarters · filed 2026-03-12 | $163.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $17.00K 10-Q · filed 2025-11-10 | $55.00K derived: sum of 2 quarters · filed 2025-11-10 | $117.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $38.00K 10-Q · filed 2025-08-12 | $100.00K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $62.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $12.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |